Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Profile Treatment Approach Name | FGFR Inhibitor (Pan) |
| Profile Name | FGFR2 rearrange |
| Drug Class | FGFR Inhibitor (Pan) 26 |
| Therapy |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (28416604) | Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib. | Full reference... |
| (31088831) | Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors. | Full reference... |
| Final results from a phase II study of infigratinib (BGJ398), an FGFR-selective tyrosine kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma harboring an FGFR2 gene fusion or rearrangement. | Full reference... |